RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Globus Medical (GMED – Research Report) yesterday and set a price target of ...

Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst ...

Medical device company Globus Medical (NYSE:GMED) reported Q4 CY2024 results , with sales up 6.6% year on year to $657.3 million. The company expects the full year’s revenue to be around $2.68 billion ...

StockNews.com lowered shares of Globus Medical (NYSE:GMED – Free Report) from a buy rating to a hold rating in a research ...

Globus Medical GMED has outperformed the market over the past 10 years by 1.79% on an annualized basis producing an average annual return of 12.81%. Currently, Globus Medical has a market ...

Welcome to the Globus Medical's Fourth Quarter and Full Year ... Looking ahead to 2025, we expect our base GMED business SG&A expense to be in the range of 37.5% to 38.5%. The GAAP tax rate ...

Allworth Financial LP reduced its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 14.3% in the fourth quarter, according to the company in its most recent 13F filing with the ...

Medical device company Globus Medical (NYSE:GMED) will be announcing earnings results tomorrow after the bell. Here’s what to expect. Globus Medical beat analysts’ revenue expectations by 3.7% ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of $100.00. The company’s shares closed last ...

Medical device company Globus Medical (NYSE:GMED) reported Q4 CY2024 results beating Wall Street’s revenue expectations , with sales up 6.6% year on year to $657.3 million. The company expects ...